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Twisted gastrulation (TWSG1) is a conserved, secreted glycoprotein that modulates signal-
ing of bone morphogenetic proteins (BMPs) in the extracellular space. Deletion of exon
4 of mouse Twsg1 (mTwsg1) is associated with signiﬁcant craniofacial defects. However,
little is understood about the biochemical properties of the corresponding region of the
protein. We have uncovered a signiﬁcant role for exon 4 sequences as encoding the only
two glycosylation sites of the mTWSG1 protein. Deletion of the entire exon 4 or mutation
of both glycosylation sites within exon 4 abolishes glycosylation of mTWSG1. Importantly,
we ﬁnd that constructs with mutated glycosylation sites have signiﬁcantly reduced BMP
binding activity. We further show that glycosylation and activity of TWSG1 recombinant
proteins vary markedly by cellular source. Non-glycosylated mTWSG1 made in E. coli has
both reduced afﬁnity for BMPs, as shown by surface plasmon resonance analysis, and
reduced BMP inhibitory activity in a mandibular explant culture system compared to gly-
cosylated proteins made in insect cells or murine myeloma cells. This study highlights an
essential role for glycosylation in Twisted gastrulation action.
Keywords: Twisted gastrulation, BMP, glycosylation, mandibular explants, Msx2, surface plasmon resonance
analysis
INTRODUCTION
Twisted gastrulation (TWSG1 in mammals, Tsg in non-mammals)
is one of several key regulators of bone morphogenetic proteins
(BMPs), including BMP2, BMP4, BMP7, in the extracellular space
(Chang et al., 2001; Ross et al., 2001; Scott et al., 2001; Blitz
et al., 2003; Zakin et al., 2005). TWSG1 is highly evolutionar-
ily conserved and mutations in Drosophila, Xenopus, and Danio
rerio Tsg disrupt normal dorsal–ventral patterning (Mason et al.,
1994; Oelgeschlager et al., 2000; Ross et al., 2001; Scott et al.,
2001). In mice, mutations in TWSG1 result in a range of cran-
iofacial defects, including micrognathia, agnathia, cyclopia, and
other midline facial defects due to abnormal development of
the ﬁrst branchial (mandibular) arch (Petryk et al., 2004; Zakin
and De Robertis, 2004; Mackenzie et al., 2009; Billington et al.,
2011).
The presumed biochemical basis of these craniofacial defects
is impaired binding of TWSG1 to BMPs. Previous work in Xeno-
pus has identiﬁed the importance of a set of conserved cysteines
and a conserved tryptophan within the N-terminus of xTsg for
binding (and inhibiting) BMPs. The C-terminus was shown to
play a role in xTsg’s interaction with chordin and BMP-promoting
activity (Oelgeschlager et al., 2000, 2003), most likely through
facilitation of Chordin (CHRD) cleavage (Larrain et al., 2001).
Deletion of exon 4 (coding exon 3), which removes neither the
cysteine-rich domain nor the C-terminus, produces similar cran-
iofacial and skeletal phenotypes to those resulting from targeting
exons 2 and 3 (coding exons 1 and 2; Nosaka et al., 2003; Zakin
and De Robertis, 2004; Gazzerro et al., 2006), raising the possi-
bility that exon 4 encodes a region of the TWSG1 protein with
important biochemical properties.
That Tsg is a glycoprotein has been known since the early
stages of characterization of this protein (Mason et al., 1994).
Despite this history, little research has actually investigated the
role of glycosylation in TWSG1 function. There are two common
types of glycosylation, N - and O-linked. In N -linked glycosy-
lation, sugar chains are linked to asparagine residues and are
generally seen in an Asn-X-Ser/Thr triplet (where X is not pro-
line; Neuberger and Marshall, 1968; Gavel and Von Heijne, 1990;
Spiro, 2002). In O-glycosylation sugar modiﬁcations occur on ser-
ines or threonines (Spiro, 2002). In this report we demonstrate
a role for exon 4-encoded sequences as the exclusive site of N -
glycosylation of mTWSG1 and show that the glycosylation of
mTWSG1 is critical for mediating BMP binding and activity of
mTWSG1.
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MATERIALS AND METHODS
ANIMAL CARE
Use and care of the mice in this study was approved by the Univer-
sity of Minnesota Institutional Animal Care and Use Committee.
Wild type mice were in the C57BL/6 background.
PROTEIN SEQUENCE ANALYSIS
Twisted gastrulationhomologprotein sequencesweredownloaded
fromNCBI forMusmusculus, Rattus norvegicus,Homo sapiens, Bos
taurus,Canis lupus familiaris,Monodelphis domestica,Gallus gallus,
andXenopus laevis. Protein sequenceswere aligned usingClustalW
in the MacVector (MacVector, Cary, NC, USA) program. Protein
phylogeny was calculated using MacVector’s phylogeny tool. Gly-
cosylation sites were predicted in each protein using EnsemblGly1
(Caragea et al., 2007) and conﬁrmed using NetNGlyc 1.02
PLASMIDS
All plasmids for expression of mTWSG1 in HEK 293 cells were
constructed in the C-terminal FLAG-tagged expression vector
pCMVTag4c (Stratagene, Santa Clara, CA, USA). A full-length
wild type Twsg1 ORF and a Twsg1 ORF lacking exon 4 were
each cloned into this vector using EcoRI and XhoI to create
pCMVTag-Twsg1WT and pCMVTag-Twsg1Δex4. Constructs with
glycosylation site mutations (pCMVTag-Twsg1N80Q, pCMVTag-
Twsg1N146Q) were generated from the wild type construct using
the QuickChange site directed mutagenesis kit (Stratagene)
employing the following primers N80Q F: 5′-atgtgcaaccctcggcagt
acagcgacaccccg, N80Q R: 5′-cggggtgtcgctgtactgccgagggttgcacat,
N146Q F: 5′-ccagctgcaccaccaacaggtgtctgttcccagc, N146Q R: 5′-
gctgggaacagacacctgttggtggtgcagctgg. The double glycosylation site
mutant was generated from the N80Q plasmid, adding the N146Q
mutation to generate pCMVTag-Twsg1QQ. A glycosylation site
at Asn51 was restored into mouse TWSG1 using the primers
P53S F: 5′-tggagaagggaactgcagctgctgtaaggagtgc and P53S R: 5′-
gcactccttacagcagctgcagttcccttctcca. Following mutation, plasmids
were assessed by restriction digests to conﬁrm mutation (RsaI for
N80Q,AﬂIII for N146Q, Pst I for P53S) and sequenced to conﬁrm
no other changes had been introduced.
For production of recombinant proteins in E. coli the cDNA
mature parts of mTWSG1 and xTsg were cloned into the expres-
sion vector pET28b(+) (Novagen, Darmstadt) via the restriction
sites NdeI and BamHI, resulting in proteins carrying an N-
terminal His6-Tag, which can be proteolytically removed using
the protease thrombin. The expression construct for recombi-
nant xTsg from insect cell expression was derived by cloning the
mature part of xTsg into a modiﬁed version of the transfer vector
pBAC3 (Novagen, Darmstadt) using the restriction sites BamHI
and XhoI. The resulting construct for xTsg harbors a gp64 signal
peptide for secretion into the medium and an N-terminal His6-
Tag, which can be removed by thrombin proteolysis. The cDNAs
encoding for mTWSG1 and xTsg were obtained from imaGenes
(Berlin) and the correctness of all cloned cDNAs was veriﬁed by
sequencing.
1http://turing.cs.iastate.edu/EnsembleGly/
2http://www.cbs.dtu.dk/services/NetNGlyc/
RECOMBINANT PROTEIN PREPARATIONS
The E. coli strain BL21(DE3) was used for bacterial protein
expression. Transformed cells were grown in shaking ﬂasks in
LB-Medium (Melford, Chelsworth) at 37˚C and 130 rpm, selec-
tion of transformed cells was achieved using 30 μg/ml kanamycin.
Gene expression was induced at an optical density of OD600 = 0.6
by adding isopropyl-1-thio-β-D-galactopyranoside (IPTG) to a
ﬁnal concentration of 1mM and protein expression was con-
tinued for 4 h and 37˚C. Cells were harvested by centrifugation
(6000× g, 15min, 4˚C) and the pellet was resuspended in TBSE
buffer (10mM Tris–HCl pH 8.0, 150mM NaCl, 1mM EDTA).
The recombinant proteins mTWSG1 and xTsg were expressed
in insoluble form as so-called inclusion bodies. To isolate the
proteins, 10 g bacterial cells were lysed on ice by sonication (Ban-
delin Sonopuls HD3200, 10min, 150W). The suspension was
centrifuged to harvest the insoluble protein fraction. Inclusion
bodies were puriﬁed by mechanical washing and centrifugation
using TBS buffer (10mM Tris–HCl pH 8.0, 150mM NaCl) with
and without 1% Triton X-100. To extract the recombinant Tsg
proteins the inclusion bodies were dissolved in 20 volumes (v/w)
100mM Na-Phosphate, 10mM Tris–HCl pH 8.0, 6M Guani-
dinium chloride (GuCl) and the mixture was stirred for 12 h
at 20˚C. After centrifugation to remove insoluble impurities
the supernatant was subjected to metal afﬁnity chromatogra-
phy (IMAC) using Ni2+-NTA resin (Amocol Bioprocedures Ltd.,
Teltow). Tsg protein was eluted employing a step gradient and
100mM Na-Phosphate, 10mM Tris pH 8.0, 6M GuCl, 300mM
imidazole. Tsg-containing fractions were pooled, dialyzed against
50mM Tris–HCl pH 8.0, 6M GuCl, 5mM EDTA and concen-
trated to a protein concentration of 5mg/ml. Refolding of Tsg
was carried out by rapid dilution using the conditions reported
for preparation of BMP2 from E. coli (Ruppert et al., 1996). The
solution containing refolded Tsg was dialyzed against 50 volumes
20mM HEPES pH 8.0, 300mM NaCl and Tsg was puriﬁed ﬁrst
by an IMAC chromatography step under non-denaturing condi-
tions. Tsg-containing fractions were pooled and dialyzed against
50 volumes 20mM HEPES pH 7.4, 500mM NaCl. As a ﬁnal
puriﬁcation step, size exclusion chromatographywas performed to
separate monomeric Tsg protein from accompanying dimeric and
oligomeric species (Superdex 75 16/60 prep grade, GE Healthcare,
Freiburg).
Recombinant xTsg protein from a eukaryotic source was gen-
erated by transient expression in baculovirus-transfected insect
cells. The virus was prepared by co-transfection of the trans-
fer vector pBAC3 containing the mature part of xTsg along
with linearized virus DNA, using the BacVector-3000 DNA Kit
(Merck KGaA, Darmstadt) into Sf9 insect cells according to the
manufacturer’s instructions. Recombinant virus was identiﬁed
and picked by a plaque-assay and protein expression was tested
from six clones during virus ampliﬁcation. A high-expression
virus clone was then ampliﬁed in Sf21 insect cells to a titer of
≥107–108 pfu/ml.
For protein production, HighFive insect cells (BTI-TN-5B1-
4, gift of R. Grabherr, VIBT, Vienna, Austria) were used, which
were grown as adherent cell cultures in IPL-41 medium sup-
plemented with 1% Penicillin/Streptomycin (LONZA, Köln) and
1% Lipid Medium Supplement (Sigma-Aldrich, München) at
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27˚C. For large-scale expression HighFive cells were transferred
to RollerBottles (Greiner Bio-One, Frickenhausen) and adapted
to suspension culture. 8× 105 cells/ml were infected with recom-
binant baculovirus at a multiplicity of infection of 5 and protein
expression was continued for additional 4–5 days. The cell suspen-
sion was clariﬁed by centrifugation (6000 g, 20min, 4˚C) and the
protein-containing supernatant was dialyzed against 20mM Tris–
HCl pH 7.9, 500mM NaCl, 20mM imidazole for IMAC puriﬁca-
tion. Pure xTsgwas eluted in a step gradient using 20mMTris–HCl
pH 7.9, 500mM NaCl, 300mM imidazole. Tsg-containing frac-
tions were pooled, dialyzed twice against 50 volumes 20mM
HEPES pH 7.4, 500mM NaCl and frozen at −20˚C until
further use.
CELL CULTURE, PROTEIN ISOLATION, AND DEGLYCOSYLATION
HEK293 cells were cultured in Dulbecco’s minimum essential
media supplemented with 10% fetal bovine serum and 1% 100×
Anti-Anti antibiotic–antimycotic (GIBCO, Carlsbad, CA, USA).
Cells were transfected using Lipofectamine with PLUS reagent
(Invitrogen, Carlsbad, CA, USA) in media without serum or
antibiotics and lysed to isolate proteins after 16 h. Proteins from
transfected cells were isolated in lysis buffer (50mM Tris–HCl,
125mM NaCl, 1% NP40 Substitute (BioChemika #74385), and
0.5% sodium deoxycholate) with the addition of Complete pro-
tease inhibitor (Roche, Indianapolis, IN, USA). Lysates were spun
for 10min at 10000 g to pellet cell debris. Supernatant fractions
were analyzed using SDS-PAGE with and without deglycosylation.
Transfection product proteins, insect cell xTsg, E. coli mTWSG1
and were deglycosylated using PNGase F (New England Bio-
labs, Ipswich, MA, USA) according to manufacturer’s instruc-
tions. Recombinant mouse TWSG1 from murine myeloma cells
(R&D systems, Minneapolis, MN, USA) was deglycosylated using
PNGase F or protein deglycosylation mix (NEB) according to
manufacturer’s instructions. Blots of FLAG-tagged proteins were
probed with 1:1000 Rabbit Anti-DYKDDDDK in 0.1% casein/PBS
(Cell Signaling, Danvers, MA, USA). Untagged recombinant pro-
teins were visualized using a rabbit antibody custom generated
(Open Biosystems, Thermo Fisher Scientiﬁc) against the peptide
EGDTQLNWNIVSFPVAEE (mTWSG1 aa.108–125) at 1:250 in
0.1% casein/PBS. All blots were pre-blocked in 0.1% casein/PBS.
IMMUNOPRECIPITATION
HEK293 cellswere transfectedwith FLAG-taggedWT,QQorΔex4
constructs while one plate was left untransfected. Cells were lysed
after 16 h in 250μl of 140mM NaCl, 0.4mM Tris–HCl pH 8.0,
1% Glycerol, 1% NP40 Substitute, 2% BSA with protease inhibitor
cocktail. Lysates were spun at 10000 g for 10min and supernatant
was combined with EZview anti-FLAG M2 afﬁnity beads (Sigma,
St. Louis, MO, USA) as well as 100 ng recombinant BMP2 (R&D).
IP beads, BMP ligand, and lysate were allowed to interact for 6 h
at 4˚C in a rotary shaker. IP beads were washed four times in
280mM NaCl, 0.4mM Tris–HCl pH 8.0, 1% Glycerol, 1% NP40
Substitute. Samples were eluted by boiling 5min in sample loading
buffer (62.5mM Tris–HCl pH6.8, 2% SDS, 10% glycerol 0.002%
bromophenol blue) and analyzed by SDS-PAGE immunoblotting.
Duplicate blots of immunoprecipitated samples were probed with
Rabbit Anti-DYKDDDDK (Cell Signaling; 1:5000) or with anti
BMP2 (R&D; 1:5000). Blots were blocked in 5% BSA and primary
antibodies were probed in 5% dry milk.
SURFACE PLASMON RESONANCE ANALYSIS
In vitro interaction analysis employing surface plasmon reso-
nance (SPR) was performed using a ProteON XPR36 system
(Bio-Rad Laboratories Inc., Technion,Haifa, Israel). Recombinant
BMP2 derived from E. coli expression was immobilized onto a
ProteOn GLC-chip (Bio-Rad Laboratories Inc., Technion, Haifa,
Israel) via amino coupling. The alginate polymer surface was ﬁrst
activated with a freshly prepared mixture of 100mM 1-Ethyl-3-
[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC) and
25mM N -hydroxysulfosuccinimide (Sulfo-NHS). Then recombi-
nant human BMP2 was immobilized on ﬂow cells 1 and 2 by
perfusing a solution of 200 nM BMP2 in 10mM sodium acetate
pH 4.0 over the activated alginate surface until protein densities of
100–200 (low density coating) and 400–500 RU (medium density
coating) on the biosensor surfacewere obtained.Non-glycosylated
xTsg and mTsg from E. coli as well as glycosylated xTsg from insect
cells were perfused as analytes over the biosensor surface. Six
different analyte concentrations were used in a one-shot kinetic
measurement setup. All measurements were performed at 25˚C
in HBST buffer (10mM HEPES pH 7.4, 500mM NaCl, 0.005%
Tween20, Sigma) using a ﬂow rate of 100μl/min. The association
phase was set to 240 s, the dissociation phase was measured for
660 s. The BMP2 biosensor surface was regenerated using a short
pulse 30 s of perfusion with 10mM glycine pH 1.5. The correct
function of the BMP2 biosensor was tested using perfusion with
the BMP type I receptor BMPRIA and the values obtained were
compared to reported binding afﬁnities in the literature (Heinecke
et al., 2009).
To account for bulk face effects a control ﬂow cell (with-
out BMP2 coating) was subtracted from all measurement ﬂow
cells. Interaction data were evaluated using the software ProteON
Manager 2.1.2 Version 2.1.2.05. Apparent equilibrium binding
constants KD were derived from the kinetic rate constants for
association ka and dissociation kd by the equation KD = kd/ka.
All measurements were performed in duplicate.
MANDIBULAR EXPLANTS
Embryos were collected at embryonic day 10.5 (E10.5). Organ
culture of mandibular processes was performed according to pre-
viously reported protocols (Jaskoll et al., 2005; Melnick et al.,
2005). Brieﬂy, the mandibular component of the ﬁrst branchial
arch was isolated by microdissection and explanted into a cul-
ture system using serum-free chemically deﬁned BGJb medium
supplemented with 0.1mg/ml ascorbic acid (Sigma) and 1% peni-
cillin/streptomycin (Cellgro, Manassa, VA, USA). Explants were
allowed to develop at 37˚C and 5% CO2 for 1 h before bead place-
ment. Beads were soaked in either 1% BSA/PBS, 100 ng/μl BMP4
(R&D systems), 50 ng/μl mTWSG1 (R&D Systems), 50 ng/μl xTsg
derived from insect cell expression or 50 ng/μl mTWSG1 pro-
duced by bacterial expression in E. coli and placed in the distal
region of the explant with microforceps. Explants were cultured
for additional 24 h following bead placement. In situ hybridization
for Msx2 was performed as previously published (Mackenzie et al.,
1992; Sasaki and Hogan, 1993).
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RESULTS
TWISTED GASTRULATION PROTEINS HAVE EVOLUTIONARILY
CONSERVED GLYCOSYLATION SITES, MAPPING IN RODENTS TO EXON 4
Analysis of the mouse TWSG1 protein sequence using the Ensem-
blGly software predicts two putative N -linked glycosylation sites,
at asparagines Asn80 and Asn146. No O-linked glycosylation sites
were predicted (Caragea et al., 2007).Other vertebrate TWSG1/Tsg
protein sequences were also analyzed. All other tetrapods also
have the two putative glycosylation sites corresponding to those
predicted in mice (Figure 1). A third putative glycosylation site
at Asn51 is widely conserved in other organisms (Vilmos et al.,
2001; Oelgeschlager et al., 2004) and has been shown in Xeno-
pus to be an active site of in vivo glycosylation (Oelgeschlager
et al., 2003). This site is not present in either mice or rats, where
a consensus serine is substituted by proline, altering the N-X-
S/T glycosylation sequon. Given that this site is widely conserved
throughout other tetrapods, we infer that a mutation speciﬁcally
in the rodent lineage led to a loss of this site. Interestingly, phyloge-
netic analysis of the protein sequences for these selected tetrapods
recapitulated the expected species phylogeny with the rodents
grouping together, themarsupial as anoutgroup to theothermam-
mals and avian and amphibian representatives on a more distant
branch.
Most notably, both predicted glycosylation sites in mouse
TWSG1 (Asn80 and Asn146) are in the region encoded by exon 4,
suggesting that deletion of this exon in rodents would completely
ablate the glycosylation of any truncated protein product.
MUTATIONAL ANALYSIS CONFIRMS PUTATIVE GLYCOSYLATION SITES
Our analysis of mTWSG1 sequences suggested that mTWSG1
is exclusively N-glycosylated. We tested this by ﬁrst deglyco-
sylating the protein using a cocktail of endoglycosidases that
is able to remove both N - and O-linked glycosylation from
recombinant mTWSG1 (data not shown). We also deglycosy-
lated the protein using PNGase F, which speciﬁcally removes
N -glycosylation directly at the asparagine–carbohydrate linkage,
and observed an equivalent increase in electrophoretic mobility
(Figure 2A). This indicated that, as predicted, mTWSG1 is solely
N -glycosylated.
Although two N -glycosylation sites are predicted in mTWSG1,
they have not been previously conﬁrmed experimentally. The only
mutational analysis performed to conﬁrm a glycosylation site on
a Tsg molecule had been done in xTsg at the site not conserved in
rodents. Therefore, we mutated each of the putative rodent glyco-
sylation sites, replacing asparagine with glutamine as had been
done on other glycoproteins (Barbosa et al., 1987; Yamaguchi
et al., 1991; Buller et al., 1994), reasoning that this would pre-
vent glycosylation without disrupting the overall protein structure
(Figure 2).
As expected, expression of an exon 4 deletion mutant con-
struct (TWSG1Δex4) showed no change in protein mobility with
PNGase F treatment, indicating the expected lack of glycosylation
(Figure 2B). Mutating either Asn80 or Asn146 alone to glutamine
increased electrophoretic mobility compared to the wild type pro-
tein (Figures 2C,D). Notably, whereas the wild type protein runs
on SDS-PAGE as a doublet of roughly 27 and 30 kD, the mutant
forms no longer show the 30-kD band and instead run as dou-
blets of ∼25 and 27 kD. These single mutant proteins showed
further increased mobility, to a single band at ∼25 kD, the mole-
cular weight predicted for the unmodiﬁed amino acid sequence,
when treated with PNGase F, suggesting that they were still gly-
cosylated, although to a lesser degree than the wild type protein.
When both mutations were combined, no change in mobility with
PNGase treatment was observed and a single band was observed at
∼25 kD, indicating a complete lack of glycosylation in the double
mutant (Figure 2E).
FIGURE 1 |Twisted gastrulation is a conserved glycoprotein with
predicted conserved and non-conserved glycosylation sites. ClustalW
aligned proteins from various tetrapods are shown to highlight the high
degree of conservation of theTwisted gastrulation protein and to show the
locations of conserved and non-conserved glycosylation sites. A protein
phylogenetic tree is shown at left, which also correlates with species
phylogeny. The alignment of the protein sequences to the mouse is shown at
the top. The forth exon deleted in a mouse knockout with craniofacial defects
(Petryk et al., 2004) is indicated by a dashed line. The N -glycosylation sequons
are indicated in context below with brackets at the bottom indicating the
N-X-S sequons, while arrows in yellow or blue at the top indicate the
asparagines to which sugars can be linked.
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FIGURE 2 |Twisted gastrulation in rodents is N -glycosylated at two
residues, both in exon 4. (Top) Locations of mutations that remove or add
glycosylation at conserved sites are shown with reference to the
sequences in rodents and other tetrapods. (A)Wild type mTWSG1 is
glycosylated and runs on SDS-PAGE as a doublet of about 27 kD and 30 kD.
(B) Exon 4-deleted mTWSG1 is not glycosylated. (C)The N80Q mutation
removes one glycosylation site but is still glycosylated. (D)The N146Q
mutation removes one glycosylation site but the protein is still glycosylated.
(E)When the N80Q and N146Q mutations are combined the resulting
QQ-TWSG1 is not glycosylated. (F) Mutation of a proline in mTWSG1 to the
consensus serine restores a third glycosylation site.
Based on data for xTsg in which glycosylation at Asn52 has
been shown to occur (Oelgeschlager et al., 2003), we hypothesized
that if the consensus serine at position 53 were restored in rodent
TWSG1, Asn51 of mTWSG1 would also be a glycosylation site.
As predicted, when Pro53 was mutated in the mouse sequence to
serine, a decrease in electrophoretic mobility was observed, and
a triplet of bands appeared on SDS-PAGE analysis at 27, 30, and
33 kD (Figure 2F). The glycosylation ability of this restored site
strongly suggests that other tetrapods, including humans, have
three active glycosylation sites on TWSG1.
The observation that the number of bands in SDS-PAGE
analysis roughly correlates with the number of glycosylation sites
suggests that, at least in this in vitro system, there can be an equi-
librium between fully and partially or non-glycosylated forms of
the protein.
LACK OF GLYCOSYLATION LIMITS BMP BINDING
Since TWSG1’s primary known function is to modulate BMP
activity in the extracellular space,we tested if glycosylation affected
the binding of TWSG1 to BMPs. We also wanted to conﬁrm that
the exon 4 deletion, presumed to be defective for BMP binding,
actually did prevent binding of TWSG1 to BMPs.
Immunoprecipitation of BMP2 by the wild type TWSG1, but
not by the Δex4 mutant protein nor the QQ double glycosylation
mutant, indicates that neither of these mutant proteins is able to
bind BMP2 (Figure 3). Immunoprecipitation experiments were
also performed using BMP4 protein and showed similar results
(data not shown).
FIGURE 3 | Immunoprecipitation indicates that glycosylation and exon
4 are necessary for BMP binding. Immunoprecipitation (IP) was
performed with anti-FLAG and immunoblots (IB) were probed with either
anti BMP2 (top) or anti-FLAG (bottom); BMP2 immunoprecipitates with wild
type but not glycosylation defectiveTWSG1QQ or exon 4-deletedTWSG1Δex4.
GLYCOSYLATION OF TWSG1 RECOMBINANT PROTEINS VARIES
MARKEDLY BY CELLULAR SOURCE
Cells derived from different species have variable abilities to gly-
cosylate proteins. For example, in Gram-negative bacteria gly-
cosylation is an extremely rare event, with E. coli only hav-
ing two glycoproteins, AIDA-I, and the TibA adhesin, both of
which are potential virulence factors (Lindenthal and Elsinghorst,
1999; Benz and Schmidt, 2001). To allow for the heterologous
expression of O- or N -glycosylated proteins from bacteria, a
very complex setup is required using either coexpression of cer-
tain UDP-GlcNac epimerase and transferase enzymes (Henderson
et al., 2011) or the transfer of the glycosylation machinery of
another bacterium, i.e., from the ε-proteobacterium Campylobac-
ter jejuni into E. coli (Wacker et al., 2002). Thus mammalian
glycoproteins are usually obtained in unglycosylated form when
expressed in E. coli. On the other hand, insect cells are able to
glycosylate these proteins although they may do so with slightly
different sugar moieties and generally reduced saccharide chain
complexity (Jarvis et al., 1998; Tomiya et al., 2004). Here N -
glycosylation usually displays a high-mannose type unless engi-
neered insect cells are used, which can mimic mammalian-type
glycosylation. Following a common approach for investigating the
role of sugar modiﬁcations on proteins (Walsh and Jefferis, 2006),
we exploited this naturally occurring variation in glycosylation
modiﬁcation to test the biochemical and biological properties of
mTWSG1.
We expressed TWSG1/Tsg in E. coli, which do not glycosy-
late the protein, as well as in HighFive insect cells, which should
glycosylate the protein, and also used a commercially available
preparation of mTWSG1 produced in murine myeloma cells for
comparison. When we treated TWSG1/Tsg proteins with PNGase
F and analyzed them by electrophoresis, we were able to con-
ﬁrm differences in glycosylation (Figure 4). Murine TWSG1 made
in murine cells was fully glycosylated. Xenopus Tsg made in the
HighFive insect cell line was also N -glycosylated, although this
glycosylation may differ in the kinds or size of sugar moieties
compared to mammalian glycosylation, since the shift in elec-
trophoretic mobility was less than the apparent mobility shift
observed upon deglycosylation of mTWSG1 from murine cells.
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FIGURE 4 |TWSG1 glycosylation varies depending on host source.
mTWSG1 made in murine myeloma cells is markedly glycosylated as
indicated by the increase in mobility with PNGase F treatment. Xenopus
Tsg made in insect cells is also glycosylated but shows a smaller mobility
shift. MurineTWSG1 made in E. coli is not glycosylated and shows no shift
in mobility after treatment with PNGase F.
Murine TWSG1 made in E. coli was not glycosylated and hence
showed no change in mobility with PNGase F treatment.
LACK OF GLYCOSYLATION DECREASES THE AFFINITY OF THE
BMP–TWSG1 INTERACTION
Our immunoprecipitation data suggest that TWSG1 can bind
BMP2/4 only when glycosylated. However, SPR analysis allows for
a more precise quantiﬁcation of this change in afﬁnity. To mea-
sure the afﬁnity of the Tsg proteins for BMP2, the ligand BMP2
was immobilized on a biosensor chip surface by amino coupling.
Varying concentrations of xTsg or mTWSG1 proteins made in
insect cells or E. coli, respectively, were allowed to perfuse over the
BMP2 biosensor surface and association and dissociation kinetics
weremeasured (Figure 5). Quantitative analysis of the sensorgram
reveals that glycosylated xTsg has a three to four-fold slower dis-
sociation rate compared to non-glycosylated xTsg derived from E.
coli (Table 1; Figures 5A,B) and also a three-fold faster associa-
tion. The change in association and dissociation kinetics results
in an approximately 10-fold increased afﬁnity of N -glycosylated
xTsg compared to the non-glycosylated form for BMP2. The dif-
ference in afﬁnity and binding kinetics becomes most apparent by
a overlay of two SPR sensorgrams of insect cell derived xTsg and E.
coli derived xTsg at identical protein concentrations (Figure 5C).
Despite large efforts mTWSG1 could not be obtained from
insect cell expression, however mTWSG1 could be produced in
sufﬁcient quantities in E. coli using the same expression and
puriﬁcation scheme as used for the production of xTsg. Measur-
ing the interaction of BMP2 and mTWSG1 from E. coli via SPR
also revealed a fast dissociation rate constant. In contrast to the
interaction of xTsg and BMP2 the binding of mTWSG1 to BMP2
Table 1 |Tsg affinity for BMP2 varies depending on host source.
Ligand kon [M−1s−1] koff [s−1] KD [nM]
xTsg from insect cells 11±0.8×104 2.0±0.5×10−4 2.5
xTsg from E. coli 3.8±1×104 7.1±0.5×10−4 20.2
mTWSG from E. coli 4.4±0.3×104
(10.7±3×104)a
7.6±1.3×10−4
(2.0±0.3×10−2)
39.6 (301)
aValues in parenthesis denote low afﬁnity interaction of the biphasic interaction
between mTWSG1 and BMP2.
exhibited a biphasic binding kinetics, which could not be analyzed
by a simple 1:1 Langmuir type interaction model (Figure 5D).
Instead one interaction showed a fast association (on-rate) and a
fast dissociation (off-rate) whereas the other interaction exhibited
a slow on- and a slow off-rate. From the latter kinetics binding
parameters could be deduced that were very similar to the ones
determined for xTsg derived from E. coli (Table 1). Although we
have no explanation why mTWSG1 shows two different binding
kinetics for binding to BMP2 the comparison of mTWSG1 and
xTsg produced in E. coli clearly suggests that the presence of the
carbohydrate leads to a signiﬁcant increase in binding afﬁnity for
BMP2.
TWSG1 PROTEINS HAVE DIFFERENT BIOLOGICAL ACTIVITY DEPENDING
ON EXPRESSION SYSTEM AND GLYCOSYLATION
To demonstrate the biological effect of glycosylation loss, we
chose a mandibular explant system, which has been used previ-
ously to examine the activity of BMPs and BMP binding proteins
(Ekanayake and Hall, 1997; Tucker et al., 1998; Mina et al., 2002).
Expression of the gene Msx2 was used as a reporter to assay of the
effect of TWSG1/Tsg on BMP signaling in these explants.
As previously shown (Semba et al., 2000), treatmentwith BMP4
strongly induced Msx2 expression (Figure 6A). When a bead
soaked with glycosylated mTWSG1 (expressed in murine cells)
was placed in the Msx2 expression zone the TWSG1 was able
to suppress Msx2 expression indicating local inhibition of BMP
signaling (Figure 6B). Glycosylated xTsg from insect cells was sim-
ilarly able to suppress Msx2 expression, indicating the competency
of N -glycosylated protein from a different species and a heterolo-
gous expression system to inhibit BMP signaling (Figure 6C). On
the other hand, mTWSG1 derived from E. coli expression, which
is not glycosylated, showed no repression of Msx2, suggesting that
it is unable to inhibit BMP signaling (Figure 6D). Thus, glycosyla-
tion appears to be essential for TWSG1’s BMP binding and BMP
inhibitory functions in this tissue assay.
DISCUSSION
Although mTWSG1 protein has been presumed to be glycosy-
lated since its initial characterization, the role of glycosylation
in mTWSG1 activity has not been studied in much detail. We
report here, for the ﬁrst time, that TWSG1 binding to BMPs
is dependent on N -glycosylation. We also show that reduced
BMP binding correlates with diminished TWSG1 BMP inhibitory
activity.
Ourdata complement thosepreviously published (Oelgeschlager
et al., 2003) in which mutation of a glycosylation site in xTsg led
to a stronger biological effect than that of the wild type protein.
When serine 54 of xTsg (corresponding to proline 53 in mice) was
mutated to alanine, the electrophoretic mobility of the protein was
increased. In addition, this S54A mutant showed enhanced ven-
tralizing activity compared to wild type xTsg, which the authors
attributed to increased diffusibility of the protein in the tissue.
Based on our results, it is also possible that BMP binding may
have been compromised by reduced glycosylation. We predict that
this would limit BMP binding but may not interfere with the abil-
ity of Tsg to stimulate CHRD cleavage. This model is consistent
with other results reported by Oelgeschlager et al. (2003), in which
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FIGURE 5 | SPR interaction analysis of BMP2 binding to recombinantTsg
proteins derived from different sources. Binding of recombinant Tsg
proteins to a BMP2 biosensor was analyzed using SPR. BMP2 was
immobilized on a GLC-chip via amino coupling. Indicated concentrations ofTsg
proteins were perfused over the biosensor surface, injection started at time
point 0 with a duration of 240 s (association phase) after which only buffer was
again perfused for 660 s to record the dissociation of Tsg from BMP2. (A,B).
The BMP2 biosensor was perfused with varying concentrations of (A) xTsg
derived from expression in insect cells or (B) xTsg produced in E. coli. (C) The
different dissociation rate constants between xTsg protein derived from
either a eukaryotic or a prokaryotic host is apparent from an overlay of two
normalized SPR sensorgrams recorded for the interaction of different xTsg
proteins (500 nM concentration) with BMP2. (D)The interaction of mTWSG1
derived from E. coli expression reveals a biphasic interaction with BMP2. The
binding kinetics following a slow association and a slow dissociation yields an
equilibrium binding constant very similar to that of xTsg produced in bacteria.
FIGURE 6 |TWSG1 biological activity varies depending on host source.
Mandibular explants were treated with beads soaked in ligand solutions for
24 h. In situ hybridization was performed to examine the expression of
Msx2. Bead placements are indicated with dashed white lines where less
visible due to dark Msx2 staining. Bead treatments were: (A) BMP4,
showing induction of Msx2, (B) mTWSG, expressed in murine myeloma
cells, showing suppression of Msx2 and indicating inhibition of BMP
signaling, (C) Xenopus derived from insect cell expression, with the same
result, and (D) mTWSG1 expressed in E. coli, which shows no effect on
Msx2 expression, indicating a lack of impact on BMP signaling.
they showed that N-terminal mutations of xTsg that were unable
to bind BMPs still retained BMP-promoting activity via the C-
terminus of the protein,which resulted in enhanced ventralization.
These explanations are not mutually exclusive and diffusibility
differences of variable TWSG1 glycoforms could represent an
exciting new line of investigation.
Our ﬁndings raise the possibility that TWSG1’s BMP modula-
tory activity may be dependent on, or regulated by, glycosylation
and highlight the importance of sugar modiﬁcations in extracel-
lular signaling interactions. Given that several other extracellular
BMP modulating proteins are also predicted glycoproteins, for
example CHRD (Gumienny and Padgett, 2002), CV2/BMPER
(Kamimura et al., 2004), Noggin (Groppe et al., 2002), and the
DAN family of BMP binding proteins (Stanley et al., 1998; Avsian-
Kretchmer and Hsueh, 2004), glycosylation may play a wider role
in extracellular BMP regulation than presently recognized. The
role of glycosylation in interactions of other proteins will have to
be veriﬁed however. For example, Xenopus Lefty, which plays a
role in Nodal signaling analogous to the role of TWSG1 in BMP
signaling, is also a glycoprotein but does not require glycosyla-
tion for normal function (Westmoreland et al., 2007). In addition
to the BMP binding proteins, glycosylation of the ligand itself is
also likely to play a role in regulation of extracellular signaling
as illustrated by the absolute requirement of N -glycosylation for
the speciﬁc interaction of BMP6 with its BMP type I receptor
Alk2 (Saremba et al., 2008). Likewise, given the important role of
the metalloproteinase Tolloid/Xolloid/BMP1 in regulating BMP
action in combination with TWSG/Tsg and CHRD (Larrain et al.,
2001), it is interesting that glycosylation has been identiﬁed as
regulating the activity of the metalloproteinase MT1-MMP (Wu
et al., 2004).
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Twisted gastrulation made in cells of various species may have
differential glycosylation or complete lack of glycosylation. Given
the correlation reported here between protein source, glycosyla-
tion, BMP binding activity, and biological activity, we suggest that
experiments using recombinant BMP modulating proteins should
carefully consider the source and glycosylation status of these pro-
teins. It is also interesting to speculate whether glycosylation of
TWSG1 or other proteins may be regulated at a tissue speciﬁc
level, allowing ﬁne-tuning of protein activity in various contexts.
The exon 4 deletion mutant, which led us to this line of inquiry,
is deﬁcient for normal TWSG1 activity and a lack of glycosyla-
tion may contribute to this deﬁciency and the ensuing craniofacial
phenotypes. In the mandibular explant system, application of
exogenous glycosylated mTWSG1 resulted in a reduction of Msx2
expression, consistent with TWSG1’s role as a BMP antagonist.
The interactions between TWSG1 and BMPs in vivo, however,
are more complex. Functional TWSG1 serves to establish a BMP
signaling gradient in the developing mandibular arch. Deletion
of exon 4 disrupts the interactions between TWSG1 and BMPs,
which, in affected embryos, results in loss of the BMP gradient,
more diffuse BMP signaling, and ectopic apoptosis (Mackenzie
et al., 2009). Correspondingly, the expression of BMP target gene
Msx2 is shifted ventrally at E9.5 and then mostly lost by E10.5
(Mackenzie et al., 2009; Billington et al., 2011). We believe that
loss of expression of Msx2 as well as other BMP target genes by
E10.5 is due to the loss of a proper BMP gradient and the resul-
tant apoptosis of the distal tissues of the mandibular arch. While
TWSG1 antagonizes BMP signaling within the mandibular arch
in the explant culture system,we suggest that in vivo the BMP lim-
iting action of TWSG1 can act to actually maintain proper BMP
signaling levels in mandibular development and that this action is
dependent on glycosylation of TWSG1.
Our results highlight the importance of a better understanding
of both the various signaling molecules in craniofacial develop-
ment as well as their potential post-translational modiﬁcations.
The complex extracellular regulation of BMPs has been compared
to a baroque “court of intrigue” (Bier, 2008) based on all the sur-
prising and nuanced interactions of the many players in BMP
signaling. Our study adds to this complexity by highlighting the
role of post-translational modiﬁcations.
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